MedPath

European Vaccine Initiative

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
https://www.euvaccine.eu

Clinical Trials

6

Active:0
Completed:3

Trial Phases

1 Phases

Phase 1:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
5 (100.0%)

Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso

Phase 1
Not yet recruiting
Conditions
Malaria,Falciparum
Interventions
First Posted Date
2024-10-01
Last Posted Date
2025-07-08
Lead Sponsor
European Vaccine Initiative
Target Recruit Count
69
Registration Number
NCT06618885
Locations
🇧🇫

Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso

Evaluation of Electronic Pregnancy Registers and Mobile Applications for Monitoring Pregnancy Outcomes ( EVAPREAP )

Recruiting
Conditions
Pregnancy Related
First Posted Date
2024-01-26
Last Posted Date
2025-02-26
Lead Sponsor
European Vaccine Initiative
Target Recruit Count
2000
Registration Number
NCT06225739
Locations
🇧🇯

Fondation pour la Recherche Scientifique (FORS), Cotonou, Benin

🇧🇫

Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso

🇬🇭

Kintampo Health Research Centre (KHRC), Kintampo, Ghana

and more 1 locations

Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers

Phase 1
Completed
Conditions
Plasmodium Falciparum Malaria
First Posted Date
2008-08-08
Last Posted Date
2008-08-08
Lead Sponsor
European Vaccine Initiative
Target Recruit Count
56
Registration Number
NCT00730782
Locations
🇳🇱

Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

🇳🇱

Biomedical Primate Research Centre, Rijswijk, Netherlands

GMZ2-Aluminum Hydroxide Phase I, Tübingen

Phase 1
Conditions
Malaria
First Posted Date
2006-11-09
Last Posted Date
2007-08-10
Lead Sponsor
European Vaccine Initiative
Target Recruit Count
30
Registration Number
NCT00397449
Locations
🇩🇪

Institut for Tropical Medicine, University of Tubingen, Tubingen, Germany

Sporozoite Challenge of Polyprotein Vaccinees

Phase 1
Completed
Conditions
Malaria, Falciparum
Malaria
First Posted Date
2006-09-12
Last Posted Date
2007-10-19
Lead Sponsor
European Vaccine Initiative
Target Recruit Count
26
Registration Number
NCT00375128
Locations
🇬🇧

Imperial College, University of London, London, United Kingdom

🇬🇧

Centre for Clinical Vaccinology & Tropical Medicine, University of Oxford, Oxford, United Kingdom

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath